Toll‐like receptor 9 binds single‐stranded CpG‐DNA in a sequence‐ and pH‐dependent manner
Open Access
- 5 August 2004
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 34 (9) , 2541-2550
Abstract
Toll‐like receptors (TLR) recognize bacterial and viral components, but direct interaction of receptor and ligand is unclear. Here, we demonstrate that TLR9 binds directly and sequence‐specifically to single‐stranded unmethylated CpG‐DNA containing a phosphodiester backbone. TLR9‐CpG‐DNA interaction occurs at the acidic pH (6.5–5.0) found in endosomes and lysosomes. By sequence comparison we identified a potential CpG‐DNA binding domain homologous to that described for methyl‐CpG‐DNA binding proteins. Amino acid substitutions in this region abrogated CpG‐DNA binding and led to loss of NF‐κB activation. Furthermore, chloroquine and quinacrine, therapeutic agents for autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus, directly blocked TLR9‐CpG‐DNA interaction but not TLR2‐Pam3Cys binding. Our results demonstrate direct binding of TLR9 to CpG‐DNA and suggest that the therapeutic activity of chloroquine and quinacrine in autoimmune diseases may be due to its activity as a TLR9 antagonist and inhibitor of endosomal acidification.Keywords
This publication has 39 references indexed in Scilit:
- TLR9 signals after translocating from the ER to CpG DNA in the lysosomeNature Immunology, 2004
- Binding of the Drosophila cytokine Spätzle to Toll is direct and establishes signalingNature Immunology, 2003
- Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotidesEuropean Journal of Immunology, 2003
- Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartmentsEuropean Journal of Immunology, 2002
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptorsNature, 2002
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Drosophila Toll and IL-1 receptorNature, 1991
- Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activatorVaccine, 1989
- Establishment of dorsal-ventral polarity in the drosophila embryo: The induction of polarity by the Toll gene productCell, 1985